Anti-relaxation therapy in GORD
- PMID: 11772956
- PMCID: PMC1773085
- DOI: 10.1136/gut.50.1.6
Anti-relaxation therapy in GORD
Comment on
-
Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease.Gut. 2002 Jan;50(1):19-24. doi: 10.1136/gut.50.1.19. Gut. 2002. PMID: 11772961 Free PMC article. Clinical Trial.
References
-
- Ghillebert G, Demeyere AM, Janssens J, et al. How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci 1995;40:1317–24. - PubMed
-
- Hirschowitz BI. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 1991;101:1149–58. - PubMed
-
- Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982;307:1547–52. - PubMed
-
- Holloway RH, Kocyan P, Dent J. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux. Dig Dis Sci 1991;36:1034–9. - PubMed
-
- Schoeman MN, Tippett MD, Akkermans LMA, et al. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 1995;108:83–91. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical